Steven Weber - 14 Jul 2025 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Role: Principal Accounting Officer
Signature: /s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol: PLSE
Transactions as of: 14 Jul 2025
Transactions value $: $0
Form type: 4
Filing time: 16 Jul 2025, 18:26:07 UTC
Previous filing: 20 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Weber Steven	Principal Accounting Officer	C/O PULSE BIOSCIENCES, INC., 3957 POINT EDEN WAY, HAYWARD	/s/ Kenneth B. Stratton, as Attorney-in-Fact	16 Jul 2025	0001844594

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLSE	Stock Option (right to buy)	Award	$0	+55K		$0.00	55K	14 Jul 2025	Common Stock	55K	$16.03	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Half of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option will vest in equal tranches upon the achievement of four performance-based vesting criteria tied to the Issuer's market capitalization ranging from $1.5 billion to $4.0 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.

Content

Half of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option will vest in equal tranches upon the achievement of four performance-based vesting criteria tied to the Issuer's market capitalization ranging from $1.5 billion to $4.0 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.